학술논문

Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experience
Document Type
Article
Source
In: Annals of Hematology. (Annals of Hematology, 1 September 2018, 97(9):1619-1626)
Subject
Language
English
ISSN
14320584
09395555